Advertisement

Topics

Five Prime Therapeutics Company Profile

20:02 EDT 18th March 2019 | BioPortfolio

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,600 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets for protein therapeutics.

Pipeline

Five Prime is pursuing discovery and clinical development of its product candidates both independently and in collaboration with pharmaceutical partners. This approach has been successful – to date, we have received more than $220 million under collaboration arrangements, with potential for additional milestone and royalty payments – and it has allowed us to bolster the capital resources needed to build our drug discovery platform while also expanding our pipeline of product candidates.

Five Prime are currently focused on therapies for cancer and inflammatory diseases for our own pipeline. Three drug candidates in these areas have progressed into active or imminent human clinical trials.

FP-1039 - FGF Ligand TrapMultiple Solid Tumors

FPA008 - CSF1R AntibodyAutoimmune Disease

FPA144 - FGFR2b AntibodyGastric Cancer

Updated November 2013

Location

Two Corporate Drive
South San Francisco
CA 94080
USA

Contact

Phone: 415-365-5600
Fax: 415-365-5601
Email: business.development@fiveprime.com


News Articles [1054 Associated News Articles listed on BioPortfolio]

Orchard Therapeutics Receives EMA PRIME Designation for Investigational Lentiviral Gene Therapy

NewsThe PRIME program aims to increase regulatory support for the development of therapeutics targeting areas of high unmet need.

Orchard Therapeutics: PRIME Designation in Europe and an IPO Registration

Orchard Therapeutics, with locations in Boston and London, UK, received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for OTL-300, a lentiviral gene therapy for trans...

Five Prime Therapeutics Cuts 20% of Staff as Part of Restructuring

Based in South San Francisco, Five Prime Therapeutics announced that as part of a restructuring program, it will eliminate 41 current jobs, or about 20 percent of its current headcount. The positions ...

Five Prime Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics t...

Five Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today annou...

Osiris Therapeutics Announces GrafixPL PRIME Launches October 1, 2018

Osiris Therapeutics (NASDAQ:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announces that GrafixPL PRIME™, a h...

Five Prime Therapeutics to Present at Leerink Partners Roundtable Series: Rare Disease & Oncology

Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that A...

Five Prime Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today annou...

Drugs and Medications [52 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Rhofade [allergan, inc.]

These highlights do not include all the information needed to use RHOFADE topical c ream   safely and effectively. See full prescribing information for RHOFADE topical c ream . RHOFADE ( oxymetazolin...

Oxygen [breathe easy therapeutics, inc]

NA

Veramyst [physicians total care, inc.]

These highlights do not include all the information needed to use VERAMYST safely and effectively. See full prescribing information for VERAMYST.VERAMYST (fluticasone furoate) Nasal SprayInitial U.S. ...

PubMed Articles [560 Associated PubMed Articles listed on BioPortfolio]

NK cell immune responses differ after prime and boost vaccination.

A better understanding of innate responses induced by vaccination is critical for designing optimal vaccines. Here, we studied the diversity and dynamics of the NK cell compartment after prime-boost i...

Turning distractors into targets increases the congruency sequence effect.

The congruency effect in distractor-interference tasks is typically smaller after incongruent trials than after congruent trials. Current views posit that this congruency sequence effect (CSE) reflect...

Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.

We evaluated the safety and immunogenicity of (i) an intradermal HIV-DNA regimen given with/without intradermal electroporation (EP) as prime and (ii) the impact of boosting with modified vaccinia vir...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma.

A novel PCR assay detected IgE M1 prime transcripts in nasal polyps of patients with CRSwNP and asthma, confirming that IgE switching occurred and membrane IgE-expressing B cells were resident at muco...

Clinical Trials [332 Associated Clinical Trials listed on BioPortfolio]

Increasing Individualism and Collectivism

An online survey is conducted on MTurk populations from India and USA. Participants were assigned either a condition with primes of individualism or one with primes of collectivism, before...

XIENCE PRIME SV Everolimus Eluting Coronary Stent Post Marketing Surveillance (XIENCE PRIME SV PMS)

The objective of the study is to evaluate the safety and efficacy of XIENCE PRIME SV in real world practice in Japanese hospitals.

A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.

The primary aim of this study is to investigate the possibility to replace an erythrocyte based prime solution with a crystalloid based prime solution while maintaining metabolic function....

Comparison of Heterologous Prime-Boost Vaccination Schedules of Tetravalent Dengue Virus Purified Inactivated Vaccine (PIV) and Tetravalent Dengue Virus Live Attenuated Vaccine (LAV) in Healthy Adults in a Nonendemic Region

This study is a Phase 1, randomized, open-label study of the prime-boost vaccine candidates given in the prime-boost regimen previously demonstrated to have a high level of immunogenicity ...

Effects of Extra Corporeal Circuit Prime on Electrolytes Balance and Clinical Outcome Following Cardiac Surgery

About 6000 heart operations are performed in Sweden every year. A heart-lung machine is used almost exclusively in all heart operations. This machine fills the role of heart and lungs duri...

Companies [1396 Associated Companies listed on BioPortfolio]

Prime Therapeutics LLC

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government pr...

Five Prime Therapeutics

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has develope...

Prime Health Services, Inc.

Founded in 1996 and based in Brentwood, TN, Prime Health Services (Prime Health) is a managed care company that offers a full spectrum of services, including a Preferred Provider ...

Prime Technological Services

Prime Technological Services is a contract manufacturer specializing in printed circuit board assemblies (PCBAs) and top-level box build. A leader in high-mix, high-complexity pro...

Prime Health Services Inc.

Founded in 1996 and based in Brentwood, TN, Prime Health Services (Prime Health) is a managed care company that offers a full spectrum of services, including a Preferred Provider ...

More Information about "Five Prime Therapeutics" on BioPortfolio

We have published hundreds of Five Prime Therapeutics news stories on BioPortfolio along with dozens of Five Prime Therapeutics Clinical Trials and PubMed Articles about Five Prime Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Five Prime Therapeutics Companies in our database. You can also find out about relevant Five Prime Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record